NEOGEN CHEMICALS LIMITED

Registered and Corporate Office: 1002, 10th Floor, Dev Corpora Bldg, Opp. Cadbury Junction, Off Pokhran Road No. 2, Khopat, Thane - 400 601, Maharashtra, India;

Tel: +91 22 2549 7300; Fax: +91 22 2549 7399;

Corporate Identity Number: U24200MH1989PLC050919;

Neogen Chemicals Limited: IPO opens on April 24, 2019 with Price Band of Rs.212 – Rs.215 per Equity Share of Face Value of Rs. 10 each

·       Price Band: Rs. 212 to Rs. 215 per equity share of face value Rs. 10 each (the “Equity Shares”)

·       The minimum Bid lot is 65 Equity Shares and in multiples of 65 Equity Shares thereafter

·       Initial Public Offering to open on April 24, 2019 and to close on April 26, 2019

Mumbai, April  18, 2019: Neogen Chemicals Limited (the “Company”), one of India’s leading manufacturers of bromine-based, and lithium-based, specialty chemicals, proposes to open its initial public offering (“IPO”) of Equity Shares on April 24, 2019. The Anchor Investor Bid/Offer Period shall be 1(one) Working Day prior to the Bid/Offer Opening Date which is April 23, 2019.

The IPO consists of a fresh issue aggregating up to Rs. 700.00 million by the company (Fresh Issue) and an offer for sale of up to 1,699,600 equity shares by Haridas Thakarshi Kanani (Promoter Selling Shareholder) and up to 1,200,400 equity shares by Beena Haridas Kanani (‘Promoter Group Selling Shareholder’, and along with the Promoter Selling Shareholder collectively referred to as the ‘Selling Shareholders’).

The Bid/Offer Closing Date will be on April 26, 2019. Bids can be made for a minimum lot of 65 Equity Shares and in multiples of 65 Equity Shares thereafter.

The Equity Shares are proposed to be listed on BSE and NSE (the “Stock Exchanges”).

The net proceeds from the Fresh Issue are proposed to be utilized for: (i) Prepayment or repayment of all or a portion of certain borrowings availed by the Company; (ii) Early redemption of 9.8% FRCPS; (iii) Long term working capital; and (iv) General corporate purposes.

The Book Running Lead Manager (“BRLM”) to the Offer is Inga Advisors Private Limited and Batlivala & Karani Securities India Private Limited is the Co-Book Running Lead Manager (“CBRLM”) to the Offer.

This Offer is being undertaken in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (SCRR) read with Regulation 41 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended (SEBI ICDR Regulations). The Offer is being made through the Book Building Process in accordance with Regulation 26(1) of the SEBI ICDR Regulations, wherein not more 50% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (QIBs) (QIB Portion), provided that our Company may, in consultation with the BRLM and CBRLM, allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (Anchor Investor Portion), out of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. Further, 5% of the Net QIB Portion shall be available for allocation on a proportionate basis only to Mutual Funds, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIBs (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Offer Price.

Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non-Institutional Investors and not less than 35% of the Offer shall be available for allocation on a proportionate basis to Retail Individual Investors in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Offer Price. All Bidders, other than Anchor Investors, shall participate in the Offer mandatorily through the Applications Supported by Blocked Amount (ASBA) process by providing the details of their respective bank accounts in which the corresponding Bid Amount will be blocked by the SCSBs, or under the UPI Mechanism. Anchor Investors are not permitted to participate in the Offer through the ASBA process.

The Company and the Selling Shareholders may, in consultation with the BRLM and CBRLM consider participation by Anchor Investors in accordance with the SEBI ICDR Regulations.

All capitalized terms used herein and not specifically defined shall have the same meaning as ascribed to them in the red herring prospectus dated April 11, 2019 of the Company (the “RHP”).